Gaetano Morelli, Chief Medical Officer at Altasciences, noted: "As we learn more about GLP-1 RAs, we realize that they target many organ systems, including the pancreas, stomach, brain, heart, kidneys, immune system (due to reduced inflammation), skeletal muscle, and control of white and brown adipose tissue metabolism, with positive effects in fatty liver disease." Because these drugs address multiple chronic conditions simultaneously, they warrant broader clinical use
Not only that, but the combination of drugs also leads to impressive reductions in body weight that were significantly higher than the weight loss experienced with metformin alone
Why Non-Injectable Delivery Fails To understand why this barrier is so persistent, it helps to look at the pharmacology
Versatile effects suitable for strength and endurance athletes, seniors, and individuals with low energy levels